Decreasing Trends in Thyroid Cancer Incidence in South Korea: What Happened in South Korea?

Overview

Journal Cancer Med

Specialty Oncology

Date 2021 May 12

PMID 33979040

Citations 19

Authors

Chang-Mo Oh

Jiwon Lim

Yuh Seog Jung

Yeol Kim

Kyu-Won Jung

Seri Hong

Young-Joo Won

Affiliations

Soon will be listed here.

Abstract

Background: South Korea has the highest incidence of thyroid cancer in the world. Our study examined the trends in thyroid cancer incidence by the histologic type, cancer stage, and age group and explored possible factors that affected thyroid cancer trends.

Methods: We conducted a descriptive epidemiological study using the national cancer registry data and cause of death data from 1999 to 2016 in South Korea. Age-standardized rates were calculated using Segi's world standard population. Joinpoint regression analysis was applied to determine the changing point of thyroid cancer trends according to histologic type; Surveillance, Epidemiology, and End Results (SEER) summary stage; and age groups by sex.

Results: The age-standardized incidence of thyroid cancer in both men and women increased from 6.3 per 100,000 people in 1999 to 63.4 per 100,000 in 2012 but declined from 2012 to 2016, before the debates for over diagnosis of thyroid cancer began in 2014. The age-standardized mortality rate of thyroid cancer, incidence of distant thyroid cancer, and incidence of regional and localized thyroid cancer started to decline since early 2000, 2010, and 2012, respectively. In addition, thyroid cancer prevalence in thyroid nodules showed decreasing trends from 1999-2000 to 2013-2014.

Conclusions: The incidence of thyroid cancer began declining from 2012, before the debates for over diagnosis of thyroid cancer began in 2014. Changes in guidelines for thyroid nodule examinations may have affected this inflection point. Moreover, the debates for over diagnosis of thyroid cancer may have accelerated the decline in thyroid cancer.

Citing Articles

Thyroid cancer survival and prognostic factors in Yantai, China (2012-2022): a population-based study.

Liu H, Zhang S, Liu X, Wang Q, Zhang H, Cui W BMC Cancer. 2024; 24(1):1587.

PMID: 39736537 PMC: 11684111. DOI: 10.1186/s12885-024-13211-8.

The association between BMI and BRAFV600E mutation may differ by primary tumor size.

Park H, Heo J, Ryu H, Kim M, Oh Y, Kim T Eur Thyroid J. 2024; 13(5).

PMID: 39196534 PMC: 11466274. DOI: 10.1530/ETJ-23-0255.

Decreasing trend in thyroid cancer incidence: a study from central Italy (2007-2019).

Santelli E, Ascoli V, Dippoliti D, Michelozzi P, Cozzi I Endocrine. 2024; 86(2):510-514.

PMID: 39117778 DOI: 10.1007/s12020-024-03995-x.

Prevalence of thyroid nodule and relationship with physiological and psychosocial factors among adults in Zhejiang Province, China: a baseline survey of a cohort study.

Li X, Chen Z, Wu L, Tu P, Mo Z, Xing M BMC Public Health. 2024; 24(1):1854.

PMID: 38992649 PMC: 11238450. DOI: 10.1186/s12889-024-19375-z.

Contents analysis of thyroid cancer-related information uploaded to YouTube by physicians in Korea: endorsing thyroid cancer screening, potentially leading to overdiagnosis.

Kang E, Ju H, Kim S, Choi J BMC Public Health. 2024; 24(1):942.

PMID: 38566004 PMC: 10985908. DOI: 10.1186/s12889-024-18403-2.

References

Ahn H, Kim H . Development and implementation of clinical practice guidelines: current status in Korea. J Korean Med Sci. 2012; 27 Suppl:S55-60. PMC: 3360175. DOI: 10.3346/jkms.2012.27.S.S55. View

Davies L, Welch H . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295(18):2164-7. DOI: 10.1001/jama.295.18.2164. View

Jung K, Won Y, Kong H, Lee E . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016. Cancer Res Treat. 2019; 51(2):417-430. PMC: 6473271. DOI: 10.4143/crt.2019.138. View

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

Oh C, Cho H, Won Y, Kong H, Roh Y, Jeong K . Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea. Cancer Res Treat. 2017; 50(3):729-737. PMC: 6056982. DOI: 10.4143/crt.2017.166. View

Haymart M, Davies L . South Korean Thyroid Cancer Trends: Good News and Bad. Thyroid. 2018; 28(9):1081-1082. DOI: 10.1089/thy.2018.0508. View

Jung Y, Oh C, Kim Y, Jung K, Ryu J, Won Y . Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea. PLoS One. 2018; 13(4):e0194743. PMC: 5901988. DOI: 10.1371/journal.pone.0194743. View

Cooper D, Doherty G, Haugen B, Hauger B, Kloos R, Lee S . Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167-214. DOI: 10.1089/thy.2009.0110. View

An J, Kim H, Kim S, Dralle H, Randolph G, Piantanida E . Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives. J Endocrinol Invest. 2016; 40(6):683-685. DOI: 10.1007/s40618-016-0596-4. View

10.

Ahn H, Welch H . South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide. N Engl J Med. 2015; 373(24):2389-90. DOI: 10.1056/NEJMc1507622. View

11.

Li J, Yang C, Wang J, Ou Y, Ho H, Cheng C . Unsuspected prostate cancer after cystoprostatectomy: a comparison between two periods in taiwan. J Formos Med Assoc. 2009; 108(5):409-13. DOI: 10.1016/S0929-6646(09)60085-1. View

12.

Chung J . Unfounded reports on thyroid cancer. J Korean Med Sci. 2014; 29(8):1033-4. PMC: 4129191. DOI: 10.3346/jkms.2014.29.8.1033. View

13.

Choi Y, Kim W, Kwon H, Jeon M, Han M, Kim T . Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data. Cancer. 2017; 123(24):4808-4814. DOI: 10.1002/cncr.30943. View

14.

Tunis S, Hayward R, Wilson M, Rubin H, Bass E, Johnston M . Internists' attitudes about clinical practice guidelines. Ann Intern Med. 1994; 120(11):956-63. DOI: 10.7326/0003-4819-120-11-199406010-00008. View

15.

Jung K, Won Y, Kong H, Oh C, Shin A, Lee J . Survival of korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat. 2013; 45(3):162-71. PMC: 3804727. DOI: 10.4143/crt.2013.45.3.162. View

16.

La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F . Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2014; 136(9):2187-95. DOI: 10.1002/ijc.29251. View

17.

Connor R, Chu K, SMART C . Stage-shift cancer screening model. J Clin Epidemiol. 1989; 42(11):1083-95. DOI: 10.1016/0895-4356(89)90050-4. View

18.

Welch H, Black W . Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102(9):605-13. DOI: 10.1093/jnci/djq099. View

19.

Konety B, Bird V, Deorah S, Dahmoush L . Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol. 2005; 174(5):1785-8. DOI: 10.1097/01.ju.0000177470.84735.55. View

20.

Lee Y, Chang H, Park C . Changing trends in the management of well-differentiated thyroid carcinoma in Korea. Endocr J. 2016; 63(6):515-21. DOI: 10.1507/endocrj.EJ15-0635. View